These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15166868)

  • 1. Views on recent trials and the future of hormonal therapy.
    Lobo RA
    Clin Obstet Gynecol; 2004 Jun; 47(2):424-7. PubMed ID: 15166868
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns about published data from the estrogen-progestin (HT) arm of the WHI.
    Gass M; Anderson GL; Barad D
    Am J Obstet Gynecol; 2005 Jan; 192(1):333; author reply 334. PubMed ID: 15672044
    [No Abstract]   [Full Text] [Related]  

  • 3. The Potential for Postrandomization Confounding in Randomized Clinical Trials.
    Manson JE; Shufelt CL; Robins JM
    JAMA; 2016 Jun; 315(21):2273-4. PubMed ID: 27272576
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen deficiency: In search of symptom control and sexuality.
    Loprinzi CL; Barton D
    J Natl Cancer Inst; 2000 Jul; 92(13):1028-9. PubMed ID: 10880537
    [No Abstract]   [Full Text] [Related]  

  • 5. Primum non nocere.
    Sturdee D; MacLennan A
    Climacteric; 2002 Sep; 5(3):209-10. PubMed ID: 12419077
    [No Abstract]   [Full Text] [Related]  

  • 6. The best type of trial.
    Delaney JA
    CMAJ; 2004 Jun; 170(12):1772; author reply 1773-4. PubMed ID: 15184312
    [No Abstract]   [Full Text] [Related]  

  • 7. In pursuit of the prevention of breast cancer.
    Yardley DA
    Am J Med Sci; 2000 Oct; 320(4):263-72. PubMed ID: 11061352
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A; Sturdee DW; Birkhäuser MH;
    Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646
    [No Abstract]   [Full Text] [Related]  

  • 9. The view of The International Menopause Society on the Women's Health Initiative.
    Schneider HP;
    Climacteric; 2002 Sep; 5(3):211-6. PubMed ID: 12419078
    [No Abstract]   [Full Text] [Related]  

  • 10. Invited commentary: how far can epidemiologists get with statistical adjustment?
    Petitti DB; Freedman DA
    Am J Epidemiol; 2005 Sep; 162(5):415-8; discussion 419-20. PubMed ID: 16014781
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".
    Willett WC; Manson JE; Grodstein F; Stampfer MJ; Colditz GA
    Am J Epidemiol; 2006 Jun; 163(11):1067-8; author reply 1068-9. PubMed ID: 16641306
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?
    Vercambre MN; Fournier A; Boutron-Ruault MC; Clavel-Chapelon F; Ringa V; Berr C
    Am J Epidemiol; 2007 Dec; 166(12):1451-60. PubMed ID: 17698505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal replacement therapy and ovarian cancer.
    Tiitinen A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):479-81. PubMed ID: 12047299
    [No Abstract]   [Full Text] [Related]  

  • 14. Androgens and menopause: more fuel for the fire.
    Shulman LP
    Menopause; 2006; 13(2):168-70. PubMed ID: 16645529
    [No Abstract]   [Full Text] [Related]  

  • 15. What we know about estrogen's effect on the brain.
    Mitchell JL
    Curr Womens Health Rep; 2002 Oct; 2(5):382-9. PubMed ID: 12215311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement grows; some experts worried.
    Blume E
    J Natl Cancer Inst; 1996 May; 88(10):637-9. PubMed ID: 8627638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials].
    Arnesen H; Qvigstad E
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
    Stehouwer CD
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):61-4. PubMed ID: 11225257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rashomon revisited: two views of monitoring the Women's Health Initiative trials.
    Goodman SN
    Clin Trials; 2007; 4(3):205-6. PubMed ID: 17715245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse cardiovascular effects of postmenopausal hormone replacement therapy].
    Middeldorp S; Büller HR; Vandenbroucke JP; Helmerhorst FM; Rosendaal FR
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2123-7. PubMed ID: 12474549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.